Page last updated: 2024-08-21

isoxazoles and Central Nervous System Diseases

isoxazoles has been researched along with Central Nervous System Diseases in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19904 (33.33)18.7374
1990's1 (8.33)18.2507
2000's1 (8.33)29.6817
2010's6 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gaens, D; Geyer, J; Hamann, M; Rummel, C; Schmidt, M1
Hwang, TJ; Jafarov, A; Jakubowiak, W; Keshavjee, S; Nunn, P; Wares, DF1
Hiramatsu, M1
Uto, Y1
Barmade, MA; Murumkar, PR; Sharma, MK; Yadav, MR1
Ceschi, A; Hofer, KE; Kullak-Ublick, GA; Kupferschmidt, H; Rauber-Lüthy, C; Trachsel, C1
Ebert, B; Frølund, B; Kristiansen, U; Krogsgaard-Larsen, P; Liljefors, T1
Cripps, C; Eisenhauer, E; Fields, AL; Maroun, JA; Pater, JL; Stewart, DJ1
Jennings, FW; Miller, BM; Murray, PK; Urquhart, GM1
Anderson, DJ; Arneric, SP; Bannon, AW; Briggs, CA; Brioni, JD; Decker, MW; Donnelly-Roberts, D; Holladay, MW; Sullivan, JP; Williams, M1
Birch, R; Greco, A; Johnson, R; Kramer, BS; Prestridge, K1
Chang, YC; Falkson, G; Knuiman, MW; Pandya, KJ; Skeel, RT; Willson, JK; Wolter, JM1

Reviews

6 review(s) available for isoxazoles and Central Nervous System Diseases

ArticleYear
Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2013, Volume: 17, Issue:10

    Topics: Antibiotics, Antitubercular; Central Nervous System Diseases; Cycloserine; Humans; Isoxazoles; Mental Disorders; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2013
[Functional role for GABA transporters in the CNS].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2014, Volume: 143, Issue:4

    Topics: Animals; Brain; Camphanes; Carbazoles; Carrier Proteins; Central Nervous System Diseases; Drug Discovery; GABA Plasma Membrane Transport Proteins; GABA Uptake Inhibitors; Humans; Isoxazoles; Mental Disorders; Molecular Targeted Therapy; Nipecotic Acids; Piperidines; Tiagabine

2014
1, 2-Benzisoxazole: A Privileged Structure with a Potential for Polypharmacology.
    Current pharmaceutical design, 2016, Volume: 22, Issue:21

    Topics: Central Nervous System Agents; Central Nervous System Diseases; Humans; Isoxazoles; Molecular Structure; Polypharmacology

2016
Medicinal Chemistry Perspective of Fused Isoxazole Derivatives.
    Current topics in medicinal chemistry, 2016, Volume: 16, Issue:26

    Topics: Antineoplastic Agents; Cardiovascular Diseases; Central Nervous System Diseases; Chemistry, Pharmaceutical; Humans; Hypoglycemic Agents; Isoxazoles; Structure-Activity Relationship

2016
GABA(A) receptor ligands and their therapeutic potentials.
    Current topics in medicinal chemistry, 2002, Volume: 2, Issue:8

    Topics: Animals; Central Nervous System Diseases; GABA Agents; GABA Agonists; GABA Antagonists; Humans; Isonicotinic Acids; Isoxazoles; Ligands; Muscimol; Piperidines; Protein Subunits; Receptors, GABA-A

2002
Cholinergic channel activators: novel opportunities for the treatment of CNS disorders.
    Proceedings of the Western Pharmacology Society, 1995, Volume: 38

    Topics: Animals; Anti-Anxiety Agents; Benzylidene Compounds; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System Diseases; Cholinergic Antagonists; Humans; Ion Channels; Isoxazoles; Nicotinic Agonists; Parasympathetic Nervous System; Pyridines; Pyrrolidines; Receptors, Cholinergic

1995

Trials

2 trial(s) available for isoxazoles and Central Nervous System Diseases

ArticleYear
Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Cancer treatment reports, 1986, Volume: 70, Issue:8

    Topics: Antibiotics, Antineoplastic; Carcinoma, Bronchogenic; Central Nervous System Diseases; Clinical Trials as Topic; Drug Evaluation; Hematologic Diseases; Humans; Isoxazoles; Lung Neoplasms; Oxazoles

1986
Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
    Cancer treatment reports, 1986, Volume: 70, Issue:10

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Central Nervous System Diseases; Clinical Trials as Topic; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Isoxazoles; Middle Aged; Neoplasm Metastasis; Oxazoles

1986

Other Studies

4 other study(ies) available for isoxazoles and Central Nervous System Diseases

ArticleYear
Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog.
    BMC veterinary research, 2019, Aug-07, Volume: 15, Issue:1

    Topics: Animals; Central Nervous System Diseases; Dog Diseases; Dogs; Female; Insecticides; Isoxazoles

2019
Moderate toxic effects following acute zonisamide overdose.
    Epilepsy & behavior : E&B, 2011, Volume: 21, Issue:1

    Topics: Adult; Anticonvulsants; Central Nervous System Diseases; Drug Overdose; Epilepsies, Partial; Female; Humans; Isoxazoles; Zonisamide

2011
Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
    Cancer treatment reports, 1984, Volume: 68, Issue:9

    Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Central Nervous System Diseases; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Isoxazoles; Male; Middle Aged; Oxazoles; Rectal Neoplasms

1984
'Berenil' and nitroimidazole combinations in the treatment of Trypanosoma brucei infection with central nervous system involvement.
    International journal for parasitology, 1980, Volume: 10, Issue:1

    Topics: Amidines; Animals; Benzamidines; Central Nervous System Diseases; Diminazene; Ethidium; Female; Isoxazoles; Mice; Nitroimidazoles; Phenanthridines; Ronidazole; Time Factors; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African

1980